Homeright arrow
Texas Public Radio: Medical Cannabis in Texas Panel

Texas Public Radio: Medical Cannabis in Texas Panel

Bryon Adinoff, MD

Check mark
Media
|
date
June 29, 2021
|

Dr. Bryon Adinoff participated in a panel discussion for Texas Public Radio regarding recently enacted legislation for Texas' medical cannabis program.

Texas will expand access to medical cannabis for individuals with post-traumatic stress disorder and any form of cancer — not just those that are terminal — starting Sept. 1.While advocates are still chalking it up as a win for a state with one of the most restrictive medical cannabis programs in the U.S., the bill that was signed into law by Gov. Abbott was ultimately stripped of its biggest changes during the legislative process.Multiple other marijuana-related bills didn’t make it through the session at all.Lawmakers first passed the state's Compassionate Use Act in 2015 for people with intractable epilepsy and expanded the program to cover terminal cancer and neurodegenerative disorders like Alzheimer’s and Parkinson’s disease in 2019.Texas is one of 11 states with a low-THC program. This year's changes also include a slight increase to the cap for the level of allowable THC in medicinal products, from 0.5% up to 1%. The House's version would have increased the legal limit to 5%.What are the details of the new law? In what ways was it scaled back by the Texas Senate, after initial passage through the House, and why?

Listen to the panel discussion at Texas Public Radio

Share:

About the Author

Bryon Adinoff, MD

Bryon Adinoff, MD

Bryon Adinoff, MD is an addiction psychiatrist and academician. He was appointed Clinical Professor at the University of Colorado School of Medicine following his retirement as Distinguished Professor of Alcohol and Drug Abuse Research in the Department of Psychiatry at the University of Texas Southwestern Medical Center and as a psychiatrist for 30 years with the Department of Veterans Affairs. He has published over 175 papers and book chapters on the neurobiology and treatment of addiction and is Editor-in-Chief of The American Journal of Drug and Alcohol Abuse. In his semi-retired status, he is evolving from focusing on the consequences of substance use itself to the consequences of the drug war. As a Founding Member, his commitment to the goals of DFCR arises from his desire to ensure that the harsh, punitive prohibition of cannabis use is replaced by a regulatory system that protects both the individual and society.